SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea · Delayed Price · Currency is KRW 1,969.00
+85.00 (4.51%)
At close: Jun 9, 2025
SLS BIO Market Cap
SLS BIO has a market cap or net worth of 26.89 billion as of October 23, 2026. It is the 36,762nd most valuable company in the world and the 2,230th biggest in South Korea. Its market cap has decreased by 15.58% in one year.
Market Cap
26.89B
Enterprise Value
20.82B
Revenue
2.89B
Global Rank
Country Rank
#2,230 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, SLS BIO's market cap has decreased from 29.35B to 26.89B, a decrease of -8.39%. That is a compound annual growth rate of -1.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2025 | 26.89B | 2.29% |
| Dec 30, 2024 | 26.29B | -25.39% |
| Dec 28, 2023 | 35.23B | 3.72% |
| Dec 29, 2022 | 33.97B | -44.41% |
| Dec 30, 2021 | 61.11B | -20.80% |
| Dec 30, 2020 | 77.16B | 48.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 313.25B |
| DreamCIS | 104.18B |
| HLB bioStep | 103.40B |
| P&K Skin Research Center | 47.65B |
| Kolmar BioTech | 35.59B |
| DT&CRO CO. | 29.79B |
| C&R Research | 26.43B |
| Curachem | 12.65B |